Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression

Details for Australian Patent Application No. 2004305563 (hide)

International Classifications

Event Publications

27 July 2006 PCT application entered the National Phase

PCT publication WO2005/060968 Priority application(s): WO2005/060968

16 December 2010 Application Accepted

Published as AU-B-2004305563

17 March 2011 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 02 Mar 2011. Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000 2005

7 July 2011 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 02 Mar 2011 2005

14 July 2011 Standard Patent Sealed

15 September 2011 Alteration of Name

The name of the patentee has been altered to Sunovian Pharmaceuticals Inc. 2005

1 March 2012 Corrigenda

Change of Names(s) of Applicant(s), Section 104 - 2004 Under the Name Sunovian Pharmaceuticals Inc., Application No. 2004305563, under INID(71) correct the applicant name to Sunovion Pharmaceuticals Inc. Corrigenda

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.